Powered by you.
Personalized for you.
Are you a Time in Range Trooper?
Find out with a new monthly Medtronic dashboard that shares insights like you’ve never seen before, exclusively for individuals using a MiniMed™ 700 series insulin pump and Guardian™ sensors!
My Insights emails include:
What others are saying about My Insights
I received my first report yesterday. I have to say I thought I’d like…but I actually love it. I find myself looking forward to next month’s report and being motivated to make it better (like a healthy competition to see just how much I can accomplish)!"
I really enjoy seeing a one-month average of my Time in Range. Also, the recommendations along with videos are extremely helpful."
I like that it was able to identify specific tips related to my usage versus general tips."
I just received My Insights report and am so impressed! Great to see the relevant tips that it gave me. Diabetes is hard sometimes and sometimes we just need a little encouragement along the way."
This is a great way for Medtronic to be proactive to individualize my personal results, along with some tips to improve."
Very cool concept and great insights."
Get My Insights for your MiniMed™ 700 series system
As easy as 1-2-3
A MiniMed™ 780G or MiniMed™ 770G system + Diabetes.shop account + Data uploading to CareLink™ software
- If you’re already logged into Diabetes.shop, click on your profile photo to view your account details. Or log in to visit your profile page here.
- Scroll down to “Communication preferences” and click on the plus sign.
- Underneath the Personalized Insights communications category, select “On” to read the program details and provide consent. You will receive a copy of consent provided to your Medtronic email address on file.
Continue to wear your pump and sensor
Once you’ve given us permission and we have a few weeks of data, expect to get your first email. If you wear your system and data continues to upload, then you will receive monthly emails (since tips are related to the pump and sensor).
Find answers to FAQs
Once a month you will get an email from CustomerExperience@Medtronic.com.
My Insights are powered by your full system, so you won’t receive insights if you’ve taken a pump or sensor break for longer than 14 days within the last month. We look forward to getting you back on track with your My Insights email.
If that’s not the case, here are some other reasons why your data might not be uploading:
- Check to see if you’re still logged in to the MiniMed™ Mobile app.
- Make sure "Sync to CareLink™" is turned on. Here’s how: Tap on the three lines in the top left corner of the app and select the sync option. If it’s on, you will see a green bar on the next screen. If it’s turned off, you will see a white circle with no bar. Tap to turn on.
- Look at when the last app sync occurred. If it was more than 24 hours ago, tap “Upload Now”.
There are a few simple steps to check to make sure you continue to receive emails. You should be able to answer yes to each of these:
- Have you provided program consent more than two weeks ago?
- Is your data uploading to CareLink™ Personal (via the MiniMed™ Mobile app with automatic syncs turned on, or through bi-weekly manual uploads with the blue adapter)?
- Have you worn both your pump and sensor for more than two weeks in the last month?
If you meet these criteria and still need help then please call 877-379-6242 to speak with a support representative Monday-Friday, 9AM-6PM CT.
Opt in now to earn your first badge, like Melanie who is an Auto Mode Athlete!
Important Safety Information: MiniMed™ 780G System With SmartGuard™ Technology With Guardian™ 4 Sensor
The MiniMed™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 780G system includes SmartGuard™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed™ 780G system consists of the following devices: MiniMed™ 780G insulin pump, the Guardian™ 4 transmitter, the Guardian™ 4 sensor, One-press serter, the Accu-Chek™ Guide Link blood glucose meter, and the Accu-Chek™ Guide test strips. The system requires a prescription from a healthcare professional.
The Guardian™ 4 sensor is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian™ 4 sensor is indicated for up to seven days of continuous use.
The Guardian™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed™ 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ 4 sensor. The Guardian™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.
WARNING: Do not use the SmartGuard™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard™ feature.
WARNING: Do not use the MiniMed™ 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 780G system.
WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.
Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safety-information#minimed-780g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library
Important Safety Information: MiniMed™ 770G System With SmartGuard™ Technology
The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the AccuChek®Guide Test Strips. The system requires a prescription.
The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).
All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.
WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.
WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safetyinformation#minimed-770g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library
Important Safety Information: CareLink™ Software
The CareLink™ software is intended for use as a tool to help manage diabetes. The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink™ reports. The reports provide information that can be used to identify trends and track daily activities—such as carbohydrates consumed, mealtimes, insulin delivery, and glucose readings. NOTE: CareLink™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. For more details, please consult Medtronic Important Safety Information and the appropriate CareLink™ User Guide at https://www.medtronicdiabetes.com/download-library.